So far, 6 out of the 9 reported families with TRIP4 mutations presented clinically, electrophysiologically and histopathologically with a primary skeletal muscle phenotype, associated in some cases with cardiac muscle disease (cardiomyopathy), and had severe depletion or absence of ASC-1 protein. This evidence concerns the gene TRIP4 and cardiomyopathy.